- Home
- SVRE vs ALBT Comparison
SVRE vs ALBT Comparison
Compare SVRE & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRE
- ALBT
- Stock Information
- Founded
- SVRE 2014
- ALBT 2014
- Country
- SVRE Israel
- ALBT United States
- Employees
- SVRE N/A
- ALBT N/A
- Industry
- SVRE
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SVRE
- ALBT Health Care
- Exchange
- SVRE Nasdaq
- ALBT Nasdaq
- Market Cap
- SVRE 2.6M
- ALBT 2.9M
- IPO Year
- SVRE 2022
- ALBT N/A
- Fundamental
- Price
- SVRE $0.12
- ALBT $0.20
- Analyst Decision
- SVRE
- ALBT
- Analyst Count
- SVRE 0
- ALBT 0
- Target Price
- SVRE N/A
- ALBT N/A
- AVG Volume (30 Days)
- SVRE 5.3M
- ALBT 639.6K
- Earning Date
- SVRE 08-27-2024
- ALBT 11-12-2024
- Dividend Yield
- SVRE N/A
- ALBT N/A
- EPS Growth
- SVRE N/A
- ALBT N/A
- EPS
- SVRE N/A
- ALBT N/A
- Revenue
- SVRE $458,952.00
- ALBT N/A
- Revenue This Year
- SVRE N/A
- ALBT N/A
- Revenue Next Year
- SVRE $422.52
- ALBT N/A
- P/E Ratio
- SVRE N/A
- ALBT N/A
- Revenue Growth
- SVRE N/A
- ALBT N/A
- 52 Week Low
- SVRE $0.11
- ALBT $0.16
- 52 Week High
- SVRE $1.50
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- SVRE 29.85
- ALBT 42.61
- Support Level
- SVRE $0.11
- ALBT $0.16
- Resistance Level
- SVRE $0.13
- ALBT $0.30
- Average True Range (ATR)
- SVRE 0.01
- ALBT 0.03
- MACD
- SVRE 0.00
- ALBT 0.00
- Stochastic Oscillator
- SVRE 24.14
- ALBT 26.09
About SVRE SaverOne 2014 Ltd.
Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.